Urine Glucose Concentrations Research Articles

Abstract 16307: Tofogliflozin Improves Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction Mice

Introduction: Pulmonary hypertension (PH) is a syndrome of increased pulmonary artery pressure and often leads to death. Left heart diseases(LHD) are frequently complicated by PH (PH-LHD), classified group2. In particular, PH with heart failure with preserved LV ejection fraction (HFpEF) is higher prevalence metabolic syndrome and poor prognosis than LHD without PH. Tofogliflozin (TOFO) is SGLT2 inhibitor as a therapeutic agent for diabetes. Recent study revealed SGLT2 inhibitors have a beneficial effect on heart failure. However it has not been clarified that SGLT2 inhibitors affect PH-LHD. This study examined whether TOFO improved for PH-LHD. Hypothesis: We hypothesis TOFO has a protective effect for PH with HFpEF. Methods: We used two HFpEF mice models, induced by transverse aortic constriction (TAC) surgery and high fat diet (HFD). TAC model: C57BL/6J mice were subjected to TAC. Sham and TAC mice were treated with TOFO 3mg/kg in water by day or only water. After 4weeks, each mouse was measured physical data, Body weight (BW), Left ventricular weight (LV), Right ventricular weight (RV), right ventricular systolic pressure (RVSP), UCG, collected blood and urine glucose. HFD model: AKR/J mice fed a HFD for 20weeks. Regular diet and HFD mice were treated with TOHO 3mg/kg in water by day or only water. 20weeks later each mouse measured above data. Results and Conclusions: Mice treated with TOFO had significantly higher urine glucose concentrations. TAC induced left ventricular hypertrophy, increased HW/BW ratio and RVSP. However TAC+TOFO mice were reduced hypertrophy and LV/BW ratio than TAC group. Moreover TAC+TOFO mice were improved RV/LV ratio and RVSP (Figure). AKR/J+HFD groups substantially higher BW and occurred PH than RFD groups. In contrast with HFD, TOFO treated group ameliorated BW, RW/LW ratio, moreover normal RVSP. These results showed Tofogliflozin had a beneficial effect for PH with HFpEF.

Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy

Introduction: Zucker diabetic fatty (ZDF) rats are used widely as an animal model of metabolic syndrome and insulin resistance. Our study focused on the effects of high versus low dietary fat on the development of Type 2 diabetes in obese male ZDF rats (fa/fa), including biomarkers to detect early signs of hypercoagulability and vascular injury in the absence of overt thrombosis. Methods: In this study, male (5/group) 10-week-old CRL:ZDF370(obese) rats were fed low (LFD, 16.7% fat) or high fat (HFD, 60% fat) diet for 12 or 15 weeks. Cohorts of 5 rats within diet groups were scheduled for sample collection after weeks 12 and 15. Results: HFD–fed ZDF rats had oily coats, lower rates of food consumption, more accelerated weight gain and increased serum cholesterol (+15%) and triglyceride concentrations (+75%) vs. LFD–fed ZDF rats. Urinary ketones were observed only in HFD–fed ZDF rats and greater urine glucose and protein concentrations in HFD–fed ZDF vs. LFD–fed ZDF rats were seen. Hemostasis testing showed ~2-fold greater fibrinogen concentration, increased von Willebrand factor concentration, and high thrombin generation in HFD–fed ZDF vs LFD–fed ZDF rats. Increased mortality in the HFD–fed ZDF rat was attributed to exacerbations of altered carbohydrate metabolism as evidenced by ketonuria and nephropathy leading to renal failure. Discussion: This characterization shows that the ZDF rat at the age, sex and weight used in this study is highly sensitive to dietary fat content that can exacerbate prothrombotic, metabolic and renal disturbances and increase mortality.

Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes.

Urinary glucose excretion (UGE) is mainly regulated by the sodium glucose cotransporter (SGLT)-2 in the proximal tubule of kidney. Lower UGE was associated with higher extent of insulin resistance in patients with type 2 diabetes. Animal studies suggested the relation of Fibroblast growth factor 21 (FGF21) and UGE. However, little was known about the association of FGF21 and UGE in human. We conducted a study to investigate the association of serum FGF21 and low UGE in patients with type 2 diabetes. A cohort of 2066 hospitalized patients with type 2 diabetes was screened for the fasting urinary glucose concentration and fasting blood glucose in the medical records. 70 patients with high UGE and 61 patients with Low UGE were analyzed. Frozen serum samples were used for the test of FGF21 levels. The body mass index (BMI) and serum FGF21 levels were higher in low UGE group. Multivariable logistic regression indicated the association of FGF21 and low UGE after adjusting for age, sex, renal function, fasting plasma glucose, the treatment of insulin, and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index. Higher serum FGF21 levels were independently associated with low UGE in patients with type 2 diabetes.

A Simple and Sensitive Optode Sensor Glucose Based on Immobilization Benedict Into Nata Cellulose Membranes

Determination of glucose concentration in urine and blood that anyone can use at any time is Benedict reagent based chemical sensor. This optical sensor was developed by immobilizing Benedict reagent into nata cellulose as supporting material via entrapment. The nata cellulose/Benedict membrane for glucose determination has optimum condition at maximum wavelenght  of 541.57 nm, Benedict concentration of 0.4470 M, and ratio of nata cellulse mass to Benedict volume was 1:3. Characterization of optical sensor for glucose was in working range of 0-5000 ppm, limit of detection was 911,11 ppm, sensitivity was 0.0009 and reproducibility was 0.2295%.

Urine glucose concentration: A useful parameter as a surrogate for glycaemia on the first day of life in canine neonates

IntroductionHypoglycaemia is a well-known risk factor in neonatal puppies and kittens; glycaemia control is crucial during the first days of life. Kidneys immaturity provokes the presence of physiological glycosuria during the first 2–3 weeks of life in small animals. ObjectivesThe aim of this study was to evaluate the potential of glycosuria as a predictor of glycaemia in neonatal puppies during the first two weeks of life. MethodsProspective study. Thirty-three client-owned healthy neonatal puppies admitted to the Veterinary Teaching Hospital, Autonomous University of Barcelona, were included in the study and divided into four different groups according to the day of sampling (1, 4, 7, and 11 days post-delivery). Glucose levels in blood and urine samples were evaluated and compared between groups. Correlation between glucose levels in blood and urine was also determined. ResultsHypoglycaemia was diagnosed in 17.14% of the puppies and only on day 1 after delivery. A positive and significant correlation between blood and urine glucose concentration on day 1 after delivery was observed. No significant correlation between blood and urine glucose was observed on days 4, 7 and 11 after delivery. ConclusionsUrine concentration of glucose is a useful parameter to establish glycaemic status on the first day of life in canine puppies.

Basal glucose excretion in dogs: The impact of feeding, obesity, sex, and age.

BackgroundThe urine glucose (UG) measurements are an integral part of urinalyses, especially in dogs with polyuria and polydipsia. A positive dipstick result is considered pathologic for disease. This paradigm has been challenged by new ultrasensitive tests, where the manufacturers recommend tolerating slightly positive results. It implies that, as in other species, basal urine glucose losses can exceed the lower limits of detection using ultrasensitive glucose dipsticks in healthy dogs.ObjectivesWe aimed to determine whether glucose is routinely detectable using a sensitive quantitative wet chemistry method in the urine of nondiabetic, nonazotemic dogs, and investigate the impact of food intake, obesity, sex, castration status, and age.MethodsSerial UG measurements were performed in healthy clinic‐owned Beagle dogs that were randomly fasted or fed. Glucose was measured in morning urine samples from normal‐weight healthy and obese dogs, and the university's electronic database was searched for quantitative UG measurements (Gluco‐quant Enzyme Kit/Roche Diagnostics).ResultsSmall amounts of glucose were detected in 555 (99.1%) of 560 urine samples analyzed. All urine samples from the clinic‐owned Beagle dogs, as well as from privately owned obese and normal‐weight healthy dogs that tested positive for glucose. The median (range) UG concentration obtained from the university's electronic database was 0.39 (0‐1.55) mmol/L, and 2.2% of the samples tested negative. Feeding, obesity, gender, castration status, and age did not affect UG concentrations.ConclusionsStudies, including a larger number of healthy dogs, are warranted to define a cut‐off between physiologic and pathologic glucosuria.

Accuracy of urine dipstick tests and urine glucose-to-creatinine ratios for assessment of glucosuria in dogs and cats.

To assess the accuracy of automated readings of urine dipstick results for assessment of glucosuria in dogs and cats, compare visual versus automated readings of urine glucose concentration, and determine the utility of the urine glucose-to-creatinine ratio (UGCR) for quantification of glucosuria. 310 canine and 279 feline urine samples. Glucose concentration was estimated in 271 canine and 254 feline urine samples by visual assessment of urine dipstick results and with an automated dipstick reader. Absolute urine glucose and creatinine concentrations were measured in 39 canine and 25 feline urine samples by colorimetric assay with a clinical chemistry analyzer (reference standard for detection of glucosuria), and UGCRs were determined. Automated assessment of the urine dipsticks yielded accurate results for 163 (60.1%) canine urine samples and 234 (92.1%) feline urine samples. Sensitivity of the automated dipstick reader for detection of glucosuria was 23% for canine samples and 68% for feline samples; specificity was 99% and 98%, respectively. Visual readings were more accurate than automated readings for both canine and feline urine. The UGCR was significantly correlated with absolute urine glucose concentration for both dogs and cats, yet there was incomplete distinction between dipstick categories for glucose concentration and UGCR. Urine dipstick readings for dogs and cats were useful for ruling glucosuria in when the result was positive but not for ruling it out when the result was negative. The evaluated dipsticks were more accurate for detection of glucosuria in cats than in dogs. Visual dipstick readings were more accurate than automated readings. The UGCR did not appear to provide additional useful information.

A Novel Design and Analysis of High-Sensitivity Biosensor Based on Nano-Cavity for Detection of Blood Component, Diabetes, Cancer and Glucose Concentration

In this study, a novel design of an optical biosensor based on resonance cavities and with high-resolution detection is proposed in a two-domains photonic crystal (2DPhCs) with free spectral range of around FSR = 630 nm. This sensor analyzes the internal components of the blood. It also detects a cancer patient from an ordinary person in the resonant wavelength range of 1.19760511 ~ 1.19760519 μm. Besides, it has the ability to detect the presence or absence of diabetes through human tear fluid with resonant wavelengths of 1.19760511 ~ 1.19760525 μm and measures the glucose concentration in urine. An analysis has been performed to determine the concentration of glucose in the normal state urine (0-15 mg/dL), urine with 0.625, 1.25, 2.5, 5 and 10 gm/dL of glucose in the wavelength range of 1.19760504 ~ 1.19760510 μm. Detection range is 0.2 × 10 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup> RIU. The primary function of the biosensor is the resonant cavity. The average bandwidth value of the output resonant wavelength is at least equal to 0.195 nm. The quality factor of the proposed sensor at worst is 6141.56. The percentage of transmission power is between 90 % and 100 %. The total area of the biosensor is 100 μm <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup> . The sensitivity range is between 1250 nm/RIU and 10000 nm/RIU. The Figure of Merit (FOM) parameter at best is FOM = 48543 ± 118 RIU <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup> . Detections of the disease through three methods (blood, urine, and tears fluid samples) is an important advantage of the proposed structure.

P0950EFFECT OF THYROID HORMONE TREATMENT ON RENAL REABSORPTION OF GLUCOSE IN ALLOXAN-INDUCED DIABETIC RATS

Abstract Background and Aims The thyroid hormone (TH) plays an important role in glucose metabolism. Recently, we showed that the TH improves glycemia control by decreasing cytokines expression in the adipose tissue and skeletal muscle of alloxan-induced diabetic rats, which were also shown to present primary hypothyroidism. In this context, this study aims to investigate whether the chronic treatment of diabetic rats with T3 could affect other tissues that are involved in the control of glucose homeostasis, as the liver and kidney. Method Adult male Wistar rats were divided into nondiabetic, diabetic, and diabetic treated with T3 (1.5 ?g/100 g BW for 4 weeks). Diabetes was induced by alloxan monohydrate (150 mg/kg, BW, i.p.). Animals showing fasting blood glucose levels greater than 250 mg/dL were selected for the study. Results After treatment, we measured the blood glucose, serum T3, T4, TSH, and insulin concentration, hepatic glucose production by liver perfusion, liver PEPCK, GAPDH, and pAKT expression, as well as urine glucose concentration and renal expression of SGLT2 and GLUT2. T3 reduced blood glucose, hepatic glucose production, liver PEPCK, GAPDH, and pAKT content and the renal expression of SGLT2 and increased glycosuria. Conclusion Results suggest that the decreased hepatic glucose output and increased glucose excretion induced by T3 treatment are important mechanisms that contribute to reduce serum concentration of glucose, accounting for the improvement of glucose homeostasis control in diabetic rats.

Modeling of highly sensitive surface plasmon resonance (SPR) sensor for urine glucose detection

This work presents a novel structure of surface plasmon resonance (SPR) sensor for urine glucose detection. The structure consists of four layers namely gold, molybdenum disulfide (MoS2), h-BN (hexagonal boron nitride), and graphene. Here, the few-layer h-BN is used as a capping layer over the MoS2 layer. The present sensor performance has been evaluated for sensitivity, quality parameter, resonance angle shift, and accuracy of detection. Sensitivity for urine glucose concentration of 0–15 mg/dl (normal range), 0.625 g/dl, 1.25 g/dl, 2.5 g/dl, 5 g/dl and 10 g/dl are found to be 180 degree/RIU, 183.34 degree/RIU, 185.71 degree/RIU, 187.5 degree/RIU, 190.9 degree/RIU and 194.12 degree/RIU respectively. The corresponding values of quality parameters and detection accuracy are observed 14.88 /RIU, 15.15 /RIU, 15.35 /RIU, 15.5 /RIU, 15.78 /RIU, 16.04 /RIU and 0.07448, 0.09091, 0.10744, 0.12397, 0.17355, 0.27273 respectively. Hence, these enhanced performances of the present SPR biosensor makes this structure suitable for urine glucose detection as well as open a new platform in the field of medical science.

Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes

PurposeTo investigate the effect of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on inflammatory cytokines of urogenital tissue in a rat model of type 2 diabetes (T2DM) to infer pharmaceutical influence of dapagliflozin on genitourinary infection or inflammation.MethodsStudy animals were divided into the following 4 groups of 10 animals each: (1) the Otsuka Long-Evans Tokushima Fatty (OLETF)-DA group treated with dapagliflozin at 1.0 mg/kg/day, (2) the OLETF-VO group treated with voglibose at 0.6 mg/kg/day, (3) the control group (OLETF-CO) given water, and (4) the Long-Evans Tokushima Otsuka (LETO) rats were included as nondiabetic control group. Changes in blood glucose, 24-hour urine volume, and urine glucose were measured. The interleukin-1β (IL-1β) and interleukin-18 (IL-18) levels in the bladder and the urethra were quantified, respectively.ResultsThe urine glucose level and the 24-hour urine volume at 12 weeks of treatment were significantly higher in the OLETF-DA group than that in any other group (P<0.05). The cytokine analysis of the bladder and urethra showed higher IL-18 and IL-1β in the OLETF-DA and the OLETF-CO groups than that in the OLETF-VO and LETO groups (P<0.05). The cytokine levels did not differ between the OLETF-DA and the OLETF-CO groups, and the level of IL-18 in the OLETF-DA group was higher in the urethra than in the bladder.ConclusionsThis study revealed that dapagliflozin increased the urine glucose concentration, resulting in an inflammatory response remain in the urogenital tract as the untreated diabetic rats. Therefore, when treating patients with T2DM with dapagliflozin, careful attention should be paid to genitourinary infection or inflammation.

Absence of Renal Protection of an Aqueous Extract of Lemongrass (Cymbopogon citratus) Cultivated in Costa Rica, Using a Model of Acute Renal Failure in Wistar Rats

&#x0D; citratus, known as zacate de limón (lemongrass), is commonly used in Costa Rica for the treatment of "kidney diseases." Therefore, the activity as renal protector of an aqueous extract of this plant was evaluated after oral administration, in a model of acute kidney injury (AKI) in female Wistar rats. For this, an aqueous extract was characterized by thin layer chromatography and qualitative phytochemical tests. An AKI model induced by potassium chromate in female Wistar rats was carried out. The serum concentration of creatinine, sodium, potassium and glucose were determined, as well as the concentrations of creatinine, sodium, potassium, glucose and proteins in urine, together with the urinary flow determination. A histopathological analysis of the subjects’ kidneys was performed, and the presence of kidney damage was identified. The characterization of the extract by thin layer chromatography, and ferric chloride, Shinoda and Wilson tests gave negative results for phenols, tannins and flavonoids. No positive changes were observed in renal function markers in urine. No histopathological evidence of nephroprotective activity of the aqueous extract of C. citratus was found. It is concluded that the aqueous extract of C. citratus obtained by infusion does not possess nephroprotective activity at a dose of 150 mg/kg evaluated by the AKI in female Wistar rats.&#x0D;

Electrochemical assessement of the therapeutic agent of dietary nitrite in streptozotocin induced diabetic rats based on Ni-Cu/nanotitania sensor

Nitrite compounds are very important in many industrials that may cause some significant problems, but in more or less cases it has useful effect. Therefore, the present study was carried out to shed the light on the effect of nitrite on streptozotocin (STZ) inducing diabetic rats. In this study, thirty-two male Wister rats were distributed into four groups (n= 8 per group): Group (1) control group; Group (2) normal rats received NaNO2 30 mg/kg body weight; Group (3) diabetic group rats received 45 mg/kg STZ intraperitoneal (IP); Group (4) diabetic rats treated daily with NaNO2 for three months. Serum from each group was collected from rat's blood samples to measure aminotransferase (AST), alanine aminotransferase (ALT), Urea, and Creatinine. A self-assembled nanostructure titania (TiO2) based surface similar to honey cells was synthesized by a simple, fast, low-cost procedure using the 2D electrochemical cell at sequence potential from 5 V to 30 V for 2 h followed by annealed method at 350°C and 750°C for 3 h. A linear sweep voltammetry electrochemical method was used to deposit the Ni-Cu nanoparticles on titania surface providing a highly sensing platform of Ni-Cu/nanotitania array. Both the degree of sensing (46 µA mM−1) for the electrode were calculated through low detection range from 0.00 to 0.35 mM of glucose via cyclic voltammetry and amperometery techniques. By increasing the glucose concentration through the detection range from 0.4 to 2.5 mM the sensitivity increased to 248 µA mM−1. This significant change indicates that the sensitivity of the electrode is suitable for diabetes measurements. We reported for the first electrochemical sensor fabricated from Ni-Cu/nanotitania to detect glucose level in real urine samples and we used this level as a marker for the effect of nitrite present in the drinking water. The results showed that the presence of low concentration of sodium nitrite can enhance the liver and kidney functions in diabetic rats and also lead to the decrease of the glucose concentration in urine. Additionally, Ni-Cu/nanotitania sensor also has stability, profitable good reproducibility and applicability that guarantee its value in the medical applications as in the environmental applications that has been proven previously.

P4466Empagliflozin improves heart function after myocardial infarction in the rat

Abstract Background Selective Sodium-glucose cotransporter 2 (SGLT2) inhibition with Empagliflozin reduced progression of left ventricular dysfunction and improved tolerance of physical exercise in heart failure by normoglycemic rats. Here, we hypothesized that Empagliflozin prevents cardiac dysfunction after myocardial infarction (MI). Purpose This study aimed to investigate whether Empagliflozin protects the heart in the early phase after experimental MI in normoglycemic rats. Methods MI was induced in Wistar rats via permanent ligation of the left coronary artery. Treatment with Empagliflozin (1 mg/kg/daily per os) was started after MI and continued for 7 days. Sham operated and vehicle treated animals served as controls (n=8). Hemodynamic parameters were measured via transthoracic echocardiography and intracardiac Samba catheter. Glucose concentration was determined in serum and urine. Protein expression of Na+/H+ exchanger isoform-1 (NHE-1), sodium bicarbonate co-transporter (NBC), Sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA), transforming growth factor beta 1 (TGF-beta1), Smad2 in the left ventricle were also studied. Additionally, NHE-1 regulation was investigated in cardiomyocyte cell line H9c2. Results Systolic heart function was improved in Empagliflozin treated MI animals compared to vehicle as demonstrated by Global Longitudinal Strain (GLS) (20,9% vs. 16,6%; p&lt;0.05). E/A ratio was decreased by tendency and blood pressure was not affected. Ejection fraction (p&lt;0.05), fractional shortening (p&lt;0.05), stroke volume (p&lt;0.01) were increased in Empagliflozin treated control rats as compared with the sham group. Moreover, application of Empagliflozin (1mg/kg, i.v. bolus) to healthy rats in 30 min increased maximal pressure in the left ventricle as compared with vehicle (110,5±15,3 mmHg vs 79,1±11,9 mmHg; p&lt;0.05). Parallel, dP/dtmax was increased while dP/dtmin was decreased by tendency. Empagliflozin treatment did not affect glucose concentration in serum and urine. Treatment of cardiac H9c2 cells with Empagliflozin (1μM) down-regulated NHE-1 by 27%. Conclusion SGLT2 inhibitor Empagliflozin improved systolic function in the early phase post MI independently from glucose regulation. The cardioprotective mechanisms of SGLT2 inhibitors may involve cardiac NHE-1 exchanger inhibition.

Semiquantitative glucose measurements in urine samples and urine soaked cat litter

Semiquantitative urine glucose measurements are a proposed alternative for the treatment surveillance of unmanageable diabetic cats. The primary objectives of this study were to determine the accuracy of 5 commercially available dipsticks, to re-evaluate a technique for detecting glucosuria in urine-soaked "clumping" type of cat litter described by Schaer and to validate a cat toilet with a sieve bottom. A total of 93 urine samples were analysed using 5 different urine dipsticks. The correlation with a laboratory reference method and the diagnostic accuracy to diagnose pathological glucosuria > 1.48 mmol/l and urinary glucose concentrations ≥ 13.9 mmol/l (therapeutically important cut-off) were determined. Furthermore, the viability of 10 types of cat litter, a cat toilet with sieve bottom, 2 disinfectants, 2 cleaning agents and 2 cat litter deodorants were tested. The correlations of the dipstick results with the reference method were moderate (rSP = 0.633) to good (rSP = 0.846). The sensitivities and specificities to diagnose pathological glucosuria were 0.7-1 and 0.94-1, respectively. Urine glucose concentrations ≥ 13.9 mmol/l were detected with sensitivities of 0.65-1 and specificities of 0.97-1. Four cat litters, one dipstick and a disinfectant containing hydrogen peroxide caused false-positive colour reactions. Depending on the dipsticks and litter used, the measurements from soaked cat litter reduced the urine glucose concentrations by a median of 70-77 %. Pouring the probes into the cat toilet and subsequent measurements from the collecting tank did not falsify the results. Not all urine dipsticks are suitable to monitor insulin therapy in diabetic cats. False positive colour reactions are possible when using dipsticks with high analytical sensitivities, some cat litters and oxidizing disinfectants. Measurements from the collecting tank of the cat toilet are superior to measurements using soaked clumping type of cat litter.

An Equipment-Free, Paper-Based Electrochemical Sensor for Visual Monitoring of Glucose Levels in Urine.

A novel electrochemical glucose sensor was created for a simple but semiquantitative visual screening of specific glucose concentrations in urine. This noninvasive glucose biosensor integrated a disposable, paper-based sensing strip and a simple amplifier circuit with a visual readout. The paper strip consisted of five enzyme-activated electrodes. Each electrode was connected to a specific indicator circuit that triggered a light-emitting diode (LED) when a predefined glucose concentration was reached. The device features (1) low-cost, disposable, paper-based glucose oxidase (GOx)/poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) sensing electrodes, (2) simple signal amplification, and (3) on-site, rapid, and visual detection. The sensor generated reliable, discrete visual responses to determine five glucose levels (1, 2, 3, 4, and higher than 4 mM) in urine in less than 2 min. This innovative approach will provide a simple but powerful glucose sensing paradigm for use in POC diagnostics.

Fabrication of Repeatedly Usable Pt-Electrode Chip Coated With Solidified Glucose Oxidase and Ascorbate Oxidase for the Quantification of Glucose in Urine

A repeated usable electrode sensor for the measurement of glucose in urine has been developed. For improvement of the selectivity in measuring glucose in urine, we fabricated the Pt electrode coated with multilayered composite of glucose oxidase (GOX) and ascorbate oxidase (AOX). This simple layer structure could deliver more electrons from glucose oxidation without interference from ascorbic acids by first oxidizing the ascorbic acids present in urine. Results showed that our newly developed Pt electrode is capable of quantifying the concentrations of glucose in urine in the range between 0 and 1000 mg/dL, as well as maintaining its detection stability during 200 times of repeated measurements. This repeatable use of the sensor is attributable to the solidified structure of AOX and GOX layer.

A promising method for diabetes early diagnosis via sensitive detection of urine glucose by Fe[sbnd]Pd/rGO

To develop a highly sensitive colorimetric detection method for the diabetes early diagnosis by determining the glucose in urine instead of blood can avoid the painful blood collection and risks of cross infection. In this paper, novel artificial enzyme mimics were formed by loading bimetallic nanoparticle FePd on the surface of reduced graphene (rGO). Also, we proposed a FePd/rGO coupled with portable paper sensor for the detection of glucose in urine. The results indicated that urine glucose can be sensitively detected in a wide range of 1–200 μM with a limit of detection (LOD) of 1.76 μM. Most important, the color difference along with the increase of urine glucose concentration can be easily distinguished by naked eyes, which is important to its practical usage in screening and diagnosis of diabetes. Furthermore, the reason of the high sensitivity of FePd/rGO towards glucose was investigated in detail via various probing experiments. FePd/rGO has an artificial enzyme mimic activity, which can catalyze O2 and generate H2O2 from glucose oxidation. The electron transfer between FePd and H2O2 will produce •OH that can oxidize terephthalic acid (TMB) by emitting a blue color. The findings in this study provide a promising alternative for the early screening and diagnosis of diabetes.

Evaluation of Serum Status of Biochemical Indices of Liver Injury and Oxidative Stress in Rats Exposed to Warri River Levels of Pb and Other Identified Metallic Co Pollutants

This study investigated serum status of biochemical indicators of liver injury and oxidative stress in rats exposed to Warri River level of lead(Pb) alone and in the presence of metallic co-pollutants. A total of 55 albino rats (of Wistar strain) weighing an average of 150.00± 09.00g, divided into 11 groups were used for the study. Groups I and II represented the deionized and Pti borehole water controls, while groups III- XI represented the test rat groups orally treated with water containing laboratory reconstituted Warri River Pb level on one hand and in the presence of laboratory reconstituted identified metallic co-pollutants including Fe, Ca, Cu, Mn, Mg, Zn via water on the other hand. The serum biochemical –hepatotoxic indices investigated were liver/body wt. ratios, body wt. change, lipid per oxidation products, plasma ALT and AST, plasma and liver alkaline phosphatase activities, plasma catalase and superoxide dismutase activities, plasma total and conjugated bilirubin level, plasma and urine glucose concentration, and plasma and urine total protein concentration. Our findings revealed an overall significant (P&lt;0.05) decrease in liver/body wt ratios and body wt change , significant (P&lt;0.05) increase in plasma ALT and AST activities, induced ALP and ACP activities, increase in SOD and catalase activities, increased plasma and urine bilirubin concentrations, decreased plasma and increased urine total protein concentrations, increased Malondialdehyde (MDA) levels, while plasma and urine glucose levels were elevated in the groups of rats exposed to Pb only, Pb + Cu, Pb + Fe and Pb + Zn, Pb + All metallic co-pollutants, and river water relative to their respective controls (deionized water and Pti tap water groups). There was a significant (P&lt;0.05) reversal of the above parameters in the groups of rats exposed to Pb + Ca, Pb + Mn, Pb + Mg. There was also a difference in liver/weight ratio, body wt. change and all the other parameters evaluated in this study, between groups of rats treated with Warri river water relative to the laboratory reconstituted water, although the changes were not significant (P&gt;0.05). Our findings revealed that, the presence of Ca, Mg and Mn in the river water significantly (P&lt;0.05)) reversed the induced activities of ALT, AST, ACP and ALP by Pb and some identified metallic co pollutants like Cu, Fe and Zn. This study also revealed the possibility of significant (P&lt;0.05) decrease in the activities of superoxide dismutase (SOD), catalase , plasma total and direct bilirubin and lipid per oxidation products of rats exposed to Warri River level of Pb in the presence of Ca, Mg and Mn relative to the Pb only group.

3D Multilayered paper- and thread/paper-based microfluidic devices for bioassays.

In this paper we describe the fabrication of novel 3D microfluidic paper-based analytical devices (3D-μPADs) and a 3D microfluidic thread/paper-based analytical device (3D-μTPAD) to detect glucose and BSA through colorimetric assays. The 3D-μPAD and 3D-μTPAD consisted of three (wax, heat pressed wax-printed paper, single-sided tape) and four (hole-punched single-sided tape, blank chromatography circles, heat-pressed wax-printed paper, hole-punched single-sided tape containing trifurcated thread) layers, respectively. The saturation curves for each assay were generated for all platforms. For the glucose assay, a solution of glucose oxidase (GOx), horseradish peroxidase, and potassium iodide was flowed through each platform and, upon contact with glucose, generated a yellow-brown color indicative of the oxidation of iodide to iodine. For the protein assay, BSA was flowed through each device and, upon contact with citrate buffer and tetrabromophenol blue, resulted in a color change from yellow to blue. The devices were dried, scanned, and analyzed yielding a correlation between either yellow intensity and glucose concentration or cyan intensity and BSA concentration. A similar glucose assay, using unknown concentrations of glucose in artificial urine, was conducted and, when compared to the saturation curve, showed good correlation between the theoretical and actual concentrations (percent differences <10%). The development of 3D-μPADs and 3D-μTPADs can further facilitate the use of these platforms for colorimetric bioassays.